Synthomics, IncFounder, CEO
Nov. 2010 - Jun. 2020Menlo Park, California, United StatesFounded Synthomics, a biotech startup focused on DNA/RNA synthesis chemistry and instrumentation. As a first time CEO, had the amazing opportunity to take the technology from original concept at Stanford University, got initial funding through SBIR grants (NHGRI), prototyped the instrumentation and completed POC on the synthesis of oligonucleotides in a novel 1535-well format, raised private Angel and VC funding to commercialize the instrument, and then sold the company to one of the largest and most reputable suppliers of synthetic RNA and DNA in the world.